APA (7th ed.) Citation

3rd, P. W., RL, S., J, S., B, Y., WW, C., PW, I., . . . AH, D. (2005). Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators. Cancer research, 65(15), 6593. https://doi.org/10.1158/0008-5472.CAN-03-3675

Chicago Style (17th ed.) Citation

3rd, Perry WL, et al. "Human Splicing Factor SPF45 (RBM17) Confers Broad Multidrug Resistance to Anticancer Drugs When Overexpressed--a Phenotype Partially Reversed by Selective Estrogen Receptor Modulators." Cancer Research 65, no. 15 (2005): 6593. https://doi.org/10.1158/0008-5472.CAN-03-3675.

MLA (9th ed.) Citation

3rd, Perry WL, et al. "Human Splicing Factor SPF45 (RBM17) Confers Broad Multidrug Resistance to Anticancer Drugs When Overexpressed--a Phenotype Partially Reversed by Selective Estrogen Receptor Modulators." Cancer Research, vol. 65, no. 15, 2005, p. 6593, https://doi.org/10.1158/0008-5472.CAN-03-3675.